SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending as investors rotate into biotech and anticipate Phase 3 updates, with the community actively debating whether the stock's recent performance is a sign of an imminent partnership or buyout. While shareholders remain focused on the potential of VK2735 as a market-leading obesity treatment, the discussion remains polarized between long-term confidence in the drug's efficacy and frustrations over clinical timeline delays.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is trending as investors digest the appointment of a new leadership team, fueling active community speculation regarding a potential private equity buyout or hostile takeover. Traders are closely monitoring the stock's significant short interest and low valuation, with many debating whether the current price represents a long-term turnaround opportunity or a value trap.

Backblaze, Inc. operates as a cloud provider for businesses and consumers to store, use, and protect their data. The firm, through its storage cloud platform, provides a foundation for businesses, developers, IT professionals, and individuals to store, backup, and archive data, host content, manage media, and build their applications. It also offers B2 Cloud Storage and Computer Backup services. The company was founded by Timothy Nufire, Gleb Budman, Charles Jones, Kwok Hang Ng and Brian Wilson in 2007 and is headquartered in San Francisco, CA.

Backblaze Inc - Ordinary Shares - Class A

Backblaze is seeing significant momentum following a massive five-year, $335 million AI storage agreement with CoreWeave, which investors view as a major validation of the company's role in the AI infrastructure stack. Community sentiment is highly bullish as market participants monitor potential short-squeeze activity and institutional accumulation, with many traders framing the company as an essential pick-and-shovel play for the rapidly expanding AI data market.

Hyliion Holdings Corp. engages in the development of sustainable electricity-producing technology. It focuses on providing modular power plant technology that can operate on various fuel sources through the KARNO power module. The company was founded by Thomas J. Healy in 2015 and is headquartered in Cedar Park, TX.

Hyliion Holdings Corporation - Ordinary Shares - Class A

Hyliion Holdings Corp

Hyliion is experiencing a surge in investor attention as market sentiment shifts toward the energy infrastructure bottleneck facing the AI industry, with the community actively discussing the KARNO generator's potential as a fuel-flexible solution. While bullish participants are focused on recent analyst initiations and the potential for major hyperscaler partnerships, skeptics remain vocal regarding the company's historical volatility and the potential for future equity dilution.

Roundhill ETF Trust - Roundhill Memory ETF

DRAM is surging as investors pile into the memory sector to capitalize on structural AI-driven demand and the critical HBM supply bottleneck. The community is actively debating the durability of this memory supercycle, with many looking toward upcoming major earnings reports and international ADR listings as key catalysts for potential price appreciation.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals is attracting market attention as investors speculate on potential buyout interest following CEO Kevin Tang's significant personal stock accumulation and active sector rotation into biotech. Community discussion remains focused on the company's internal clinical pipeline development and a perceived lack of transparency from management, despite the stock's recent price action and high trading volume.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

IBM is trending due to a major strategic partnership with ServiceNow focused on accelerating enterprise AI adoption, IT automation, and legacy system modernization. Investors and community members are actively discussing this alliance, alongside bullish sentiment regarding the company's long-term role in quantum computing and positive analyst revisions tied to software acceleration.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending as investors weigh significant price target hikes against broad volatility in the semiconductor sector triggered by a sharp sell-off in Korean memory chip markets. While the community remains divided between those bracing for a post-earnings correction and those viewing the recent dip as a tactical buying opportunity, the focus is squarely on whether Micron's upcoming guidance will confirm sustained AI-driven demand.

Lockheed Martin Corp. is a global security and aerospace company, which engages in the research, design, development, manufacture, integration, and sustainment of technology systems, products, and services. It operates through the following business segments: Aeronautics, Missiles and Fire Control (MFC), Rotary and Mission Systems (RMS), and Space. The Aeronautics segment researches, designs, develops, manufactures, integrates, sustains, supports, and upgrades advanced military aircraft, including combat and air mobility aircraft, unmanned air vehicles, and related technologies. The MFC segment is involved in air and missile defense systems, tactical missiles and air-to-ground precision strike weapon systems, logistics, fire control systems, mission operations support, readiness, engineering support and integration services, manned and unmanned ground vehicles, and energy management solutions. The RMS segment designs, manufactures, services, and supports various military and commercial helicopters, surface ships, sea and land-based missile defense systems, radar systems, sea and air-based mission and combat systems, command and control mission solutions, cyber solutions, and simulation and training solutions. The Space segment includes the production of satellites, space transportation systems, and strategic, advanced strike, and defensive systems. The company was founded in 1995 and is headquartered in Bethesda, MD.

Lockheed Martin Corp.

Lockheed Martin is trending as investors weigh strong institutional demand and significant multi-billion dollar missile defense contract wins against ongoing margin concerns and a recent dip in sector sentiment. The community remains focused on the company's role in the 'Golden Dome' initiative and its critical position in the defense supply chain, with active debates centered on whether to bet on legacy primes like LMT or emerging defense-tech disruptors.

Stellantis NV engages in the designing, engineering, manufacturing, distributing, and selling of vehicles and components. It offers its products under the Abarth, Alfa Romeo, Chrysler, Citroën, Dodge, DS Automobiles, Fiat, Jeep, Lancia, Maserati, Opel, Peugeot, Ram Trucks, Vauxhall, Free2move, and Leasys brands. The company was founded on April 1, 2014 and is headquartered in Hoofddorp, the Netherlands.

Stellantis N.V

Stellantis is trending as investors weigh a major strategic reset, headlined by a significant $26 billion charge to realign its product portfolio and shift focus away from aggressive EV mandates toward customer-preferred hybrids and internal combustion models. While the community is actively debating the company's long-term viability and the impact of suspending its dividend, bullish sentiment is emerging among those viewing the stock as an undervalued turnaround play positioned for a rebound once the restructuring takes hold.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Apadran

If_ur_not_first_ur_last

Poormans Anchor

StockTwits Web

HeartBeam Inc

oleg

@nottoday800 after this trial ends there needs to be another bigger trial and then it will get FDA approval 
How about … 2028 ugh 😑 
They fed us lies about immediate commercialization.

StockTwits for iOS

 after this trial ends there needs to be another bigger trial and then it will get FDA approval 
How about … 2028 ugh 😑 
They fed us lies about immediate commercialization.

@nottoday800 
I keep on reading there are no revenue s for 2026. That should be our biggest concern and i hope FDA buys into it.

StockTwits For Android 

 
I keep on reading there are no revenue s for 2026. That should be our biggest concern and i hope FDA buys into it.